111 Capital bought a new stake in Maximus, Inc. (NYSE:MMS - Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm bought 4,841 shares of the health services provider's stock, valued at approximately $361,000.
A number of other hedge funds and other institutional investors have also bought and sold shares of MMS. V Square Quantitative Management LLC raised its position in Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock valued at $34,000 after buying an additional 180 shares during the last quarter. R Squared Ltd bought a new position in Maximus in the fourth quarter valued at approximately $54,000. IFP Advisors Inc grew its stake in Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock valued at $59,000 after purchasing an additional 302 shares in the last quarter. Farther Finance Advisors LLC grew its stake in Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock valued at $61,000 after purchasing an additional 428 shares in the last quarter. Finally, Allworth Financial LP grew its stake in Maximus by 1,638.4% in the fourth quarter. Allworth Financial LP now owns 1,495 shares of the health services provider's stock valued at $116,000 after purchasing an additional 1,409 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company's stock.
Wall Street Analysts Forecast Growth
Separately, Wall Street Zen downgraded Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.
Get Our Latest Stock Analysis on Maximus
Insider Transactions at Maximus
In related news, Director Jan Madsen sold 2,439 shares of the business's stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now directly owns 18,097 shares in the company, valued at $1,225,347.87. The trade was a 11.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Gayathri Rajan sold 7,913 shares of the business's stock in a transaction on Friday, May 30th. The shares were sold at an average price of $72.38, for a total value of $572,742.94. Following the completion of the sale, the director now owns 14,205 shares of the company's stock, valued at $1,028,157.90. This trade represents a 35.78% decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is currently owned by corporate insiders.
Maximus Stock Up 0.8%
MMS stock traded up $0.57 during mid-day trading on Tuesday, reaching $71.77. The company had a trading volume of 339,504 shares, compared to its average volume of 563,768. The company has a debt-to-equity ratio of 0.82, a current ratio of 1.72 and a quick ratio of 1.72. The stock has a 50 day simple moving average of $70.09 and a two-hundred day simple moving average of $71.45. The company has a market capitalization of $4.04 billion, a price-to-earnings ratio of 15.43 and a beta of 0.61. Maximus, Inc. has a 52 week low of $63.77 and a 52 week high of $93.97.
Maximus (NYSE:MMS - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 earnings per share for the quarter, beating analysts' consensus estimates of $1.37 by $0.64. The firm had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. The business's revenue was up 1.0% compared to the same quarter last year. During the same period last year, the company earned $1.57 earnings per share. As a group, equities analysts predict that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Saturday, May 31st. Stockholders of record on Thursday, May 15th were paid a dividend of $0.30 per share. The ex-dividend date was Thursday, May 15th. This represents a $1.20 annualized dividend and a dividend yield of 1.67%. Maximus's dividend payout ratio is currently 23.86%.
Maximus Profile
(
Free Report)
Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.
Featured Stories

Before you consider Maximus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Maximus wasn't on the list.
While Maximus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.